NEUROFIBROMA
Clinical trials for NEUROFIBROMA explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMA trials appear
Sign up with your email to follow new studies for NEUROFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Gadolinium-Free MRI dye could make brain scans safer
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…
Matched conditions: NEUROFIBROMA
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated May 17, 2026 06:47 UTC
-
Scientists track skin tumor growth in NF1 patients
Knowledge-focused CompletedThis study followed 17 adults with neurofibromatosis type 1 (NF1) to learn how their skin tumors grow and change over two years. Researchers took detailed photos and skin samples to measure tumor growth and study the genes involved. The goal was to better understand these tumors,…
Matched conditions: NEUROFIBROMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 06:22 UTC